YN, H., MY, T., PH, L., JC, C., SC, C., HI, H., . . . PH, S. (2026). Associations of Semaglutide With Skeletal Outcomes in People With Obesity, With and Without Type 2 Diabetes: A Target Trial Emulation. Diabetes, obesity & metabolism, 28(7), 5834. https://doi.org/10.1111/dom.70786
Chicago Style (17th ed.) CitationYN, Huang, Tsou MY, Li PH, Chen JC, Chen SC, Hsieh HI, Meyerowitz-Katz G, Liu YL, and Su PH. "Associations of Semaglutide With Skeletal Outcomes in People With Obesity, With and Without Type 2 Diabetes: A Target Trial Emulation." Diabetes, Obesity & Metabolism 28, no. 7 (2026): 5834. https://doi.org/10.1111/dom.70786.
MLA (9th ed.) CitationYN, Huang, et al. "Associations of Semaglutide With Skeletal Outcomes in People With Obesity, With and Without Type 2 Diabetes: A Target Trial Emulation." Diabetes, Obesity & Metabolism, vol. 28, no. 7, 2026, p. 5834, https://doi.org/10.1111/dom.70786.